4
Clinical Trials associated with Fecal Microbiota(ProgenaBiome) / Not yet recruitingPhase 1 An Open-Label Phase I Clinical Trial of Vancomycin Followed by Fecal Microbiota Transplant for the Treatment of Parkinson's Disease
FMT may significantly improve quality of life and Parkinson Disease (PD) symptom severity measurements. We hypothesize that gut microbial dysbiosis is a major contributing factor in Parkinson's disease.
/ Not yet recruitingPhase 1 An Open-Label Phase I Clinical Trial of Vancomycin Followed by Familial Fecal Microbiota Transplant in Adult Subjects With Autism Spectrum Disorder (ASD)
This is an open-label clinical trial to evaluate the benefits of familial fecal microbiota transplant following a 6-week treatment with Vancomycin in adult subjects with ASD for treatment of social deficits and language delays.
/ Not yet recruitingEarly Phase 1IIT A clinical study for the effect of the fecal microbiota transplantation on the treatment of the Irritable Bowel Syndrome
Start Date01 Aug 2019 |
Sponsor / Collaborator- |
100 Clinical Results associated with Fecal Microbiota(ProgenaBiome)
100 Translational Medicine associated with Fecal Microbiota(ProgenaBiome)
100 Patents (Medical) associated with Fecal Microbiota(ProgenaBiome)
100 Deals associated with Fecal Microbiota(ProgenaBiome)